The People's Hospital Tongling

Background: Autoimmune and cardiovascular diseases are diagnostically complex, especially when multiple rare disorders co-occur in a single patient. This study presents a comprehensive genomic analysis of a 50-year-old female patient with mixed ancestry and a history of thrombotic thrombocytopenic purpura (TTP), systemic lupus erythematosus (SLE), and left ventricular non-compaction cardiomyopathy (LVNC).

ObjectiveThis study aims to describe trends in bone cancer-related mortality from 1999 to 2020 and analyze disparities across various demographic subgroups.MethodsData were obtained from the CDC WONDER multiple cause of death database (1999–2020). Deaths of individuals aged 25 years or older with primary malignant bone cancer (ICD-10 codes C40–C41) as the underlying cause were included. AAMRs were calculated. Joinpoint regression analysis was employed to evaluate temporal trends and estimate the APC and AAPC.ResultsFrom 1999 to 2020, a total of 25,859 bone cancer deaths were reported among US adults. The overall ASMR increased from 0.528 per 100,000 (95% CI: 0.495–0.562) in 1999 to 0.599 per 100,000 (95% CI: 0.569–0.682) in 2020, with an AAPC of 0.509 (95% CI: 0.196 to 0.931; p = 0.002) over the 22-year period. Joinpoint analysis identified three distinct segments: a non-significant decrease from 1999 to 2014 (APC = –0.218, p = 0.288), a significant increase from 2014 to 2018 (APC = 4.479, p = 0.157), and a non-significant decrease from 2018 to 2020 (APC = –1.779, p = 0.424). Mortality rates were higher in males (0.712 per 100,000) than in females (0.446 per 100,000). Adults aged 85 years and older had the highest mortality rate (3.430 per 100,000). Black or African American individuals experienced a higher mortality rate (0.584 per 100,000) compared to White (0.561 per 100,000) and Hispanic or Latino (0.335 per 100,000) individuals. Geographically, the South had the highest mortality rate (0.614 per 100,000), while the Northeast had the lowest (0.444 per 100,000).ConclusionBone cancer mortality among US adults showed an overall increasing trend from 1999 to 2020, with significant disparities by age, sex, race, and geographic region. The triphasic mortality trend may reflect evolving diagnostic technologies, treatment approaches, and healthcare accessibility. These findings provide valuable insights for public health planning and resource allocation aimed at reducing the burden of bone malignancies.

BackgroundBreast cancer has the highest incidence among women. Exercise interventions are increasingly recognized as key strategies to prevent and alleviate chemotherapy side effects. Pre-exercise health-related physical fitness (HRPF) assessments are critical forensuring safety. However, investigations on HRPF during chemotherapy and its influencing factors remain limited.PurposeTo evaluate HRPF status and its influencing factors in breast cancer patients undergoing chemotherapy, informing tailored exercise rehabilitation programs.Patients and MethodsA cross-sectional study was conducted with 230 hospitalized breast cancer patients undergoing chemotherapy in a tertiary hospital in Tongling, China. Data included a general information questionnaire, the International Physical Activity Questionnaire–Short Form (IPAQ-SF), and standardized physical measurements across five HRPF dimensions.ResultsDescriptive analysis indicated that HRPF levels were suboptimal among participants. Regression analysis identified significant predictors of HRPF, including age, physical activity level, sedentary time, hemoglobin level, menopausal status, breast cancer subtypes and chemotherapy regimen (P < 0.001).ConclusionThe level of HRPF among breast cancer patients undergoing chemotherapy remains suboptimal. Healthcare professionals should develop individualized exercise rehabilitation programs based on each patient’s HRPF status and implement early assessment and intervention strategies targeting modifiable factors to enhance HRPF outcomes.

This review presents the advancements in research on risk prediction models for physical restraint among the elderly. As the global population ages, the issue of physical restraint in older adults has become increasingly prominent, making accurate risk prediction essential for enhancing their quality of life. Current Status: Physical restraint rates exhibit marked regional disparities (e.g., 84.9% in Spain vs. 1.9% in the US). Key risk factors include age ≥75, dementia, and agitation. Machine learning models achieve higher accuracy than traditional statistical approaches, but hybrid models better balance precision and interpretability. Future Directions: (1) Developing real‐time monitoring systems via sensor technology; (2) Establishing ethical frameworks for model deployment through clinician-data scientist partnerships; (3) Implementing validated tools in clinical settings to minimize restraint use. Finally, the review emphasizing the need for improved methodologies and the integration of interdisciplinary approaches to better address this complex issue.

Podocytes injury drives proteinuria in diabetic kidney disease (DKD). Exosomes derived from human umbilical cord mesenchymal stem cells (hUCMSCs) have demonstrated therapeutic potential in kidney diseases. However, the effects of hUCMSCs on podocyte injury and the underlying mechanisms in DKD remain unexplored. Four-dimensional label-free quantitative proteomics was performed on a global analysis of proteins in sorted podocytes from normal mice (NC group), db/db mice (DM group), and db/db mice treated with hUCMSCs (DMT group). HUCMSC-derived exosomes alleviated renal dysfunction and podocyte epithelial-mesenchymal transition (EMT). A total of 1765 proteins were quantified, with enrichment in pathways related to cytoskeleton organization, phagocytosis, oxidative stress, and apoptosis. Talin-1 was downregulated in diabetic podocytes but upregulated following hUCMSC treatment. Talin-1 silencing exacerbated high glucose-induced EMT. This study highlights the potential of hUCMSC-derived exosomes as a therapeutic strategy for DKD by ameliorating Talin-1-mediated podocyte EMT.

Background Maternal anemia, particularly iron deficiency anemia (IDA), affects about 30% of women globally. Iron is vital for fetal brain development, influencing myelination and oxygen transport. The extent of maternal anemia’s effect on neonatal neurodevelopment remains unclear. This meta-analysis examines how maternal anemia affects neonatal cognitive, motor, and socioemotional outcomes. Methods A systematic review and meta-analysis were conducted using PubMed, Scopus, and Web of Science, including studies published until December 2024. After screening 1,388 articles, six studies met the inclusion criteria (sample sizes: 178–636). Eligible studies examined maternal iron levels and neonatal neurodevelopment, assessed using standardized tools. Pooled effect sizes were calculated, and study quality was evaluated using the Newcastle-Ottawa Scale. Results No significant association was found between maternal anemia and neonatal habituation (p = 0.93), orientation (p = 0.76), state regulation (p = 0.90), motor maturity (p = 0.71), autonomic stability (p = 0.10), early learning composite (p = 0.65), or gross motor function (p = 0.59). Heterogeneity was low to moderate, with no publication bias detected. Conclusion Maternal anemia showed no significant short-term effect on neonatal habituation, orientation, motor maturity, or gross motor function. Future studies should assess long-term neurodevelopment to clarify potential delayed effects and refine treatment approaches.

Numerous studies have reported an increased incidence of anxiety in individuals affected by COVID-19; however, the specific molecular mechanisms underlying this association remain poorly understood. In this study, we employed the Zung Self-Rating Anxiety Scale (SAS) to assess anxiety levels in 36 asymptomatic COVID-19 patients. In parallel, we conducted a comprehensive literature-based data mining analysis to reconstruct the functional and molecular pathways linking COVID-19 and anxiety. Additionally, we performed a meta-analysis using eight independent COVID-19 case-control gene expression datasets to examine expression alterations in the literature-derived pathways. Our findings revealed that even among asymptomatic individuals, approximately 25% exhibited mild anxiety symptoms, which negatively correlated with age. The reconstructed pathways suggested that COVID-19 may contribute to cognitive decline through multisystem dysfunction and structural or functional brain abnormalities-hallmarks of anxiety disorders. The meta-analysis confirmed increased expression of four anxiety-related molecular mediators in response to COVID-19 infection: CALCA, TNF, PLAT, and PPARG, with the latter three associated with neurocognitive decline. These results provide molecular-level evidence for a bidirectional association between COVID-19 and anxiety, potentially mediated by dysregulated inflammatory cytokines and other secreted proteins. Furthermore, impaired cognitive function may serve as a critical link connecting these two conditions.

Background: Thyroid nodules are common and can be benign or malignant.Ultrasound-guided fine needle aspiration cytology (USG-guided FNAC) is a new method for differentiating these nodules, but previous studies have yet to provide consistent conclusions.The aim of the study was to explore the effectiveness of USG-guided FNAC combined with ultrasonography in diagnosing benign and malignant thyroid nodules.Materials and Methods: The study involved 87 patients who underwent thyroid ultrasound and USGguided FNAC.The results were compared with surgical and pathological findings, and the diagnostic efficiency was analyzed using ROC curves.Results: Among the 87 thyroid nodules, 22 were malignant, and 53 were benign.USGguided FNAC alone diagnosed 34 malignant and 58 benign cases, while the combined method diagnosed 25 malignant and 63 benign cases.The ROC curve analysis showed that the combined method had a higher area under the curve (AUC) compared to ultrasound or FNAC alone, indicating better diagnostic accuracy.Conclusion: Combining USG-guided FNAC with ultrasound improves the sensitivity of preoperative differential diagnosis of benign and malignant thyroid nodules.